These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 1588436)
1. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors. Arnoldus EP; Wolters LB; Voormolen JH; van Duinen SG; Raap AK; van der Ploeg M; Peters AC J Neurosurg; 1992 Jun; 76(6):997-1003. PubMed ID: 1588436 [TBL] [Abstract][Full Text] [Related]
2. Interphase cytogenetics of brain tumors. Arnoldus EP; Noordermeer IA; Peters AC; Voormolen JH; Bots GT; Raap AK; van der Ploeg M Genes Chromosomes Cancer; 1991 Mar; 3(2):101-7. PubMed ID: 1648958 [TBL] [Abstract][Full Text] [Related]
3. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions? Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670 [TBL] [Abstract][Full Text] [Related]
4. Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas. Rosso SM; van Dekken H; Krishnadath KK; Alers JC; Kros JM J Neuropathol Exp Neurol; 1997 Oct; 56(10):1125-31. PubMed ID: 9329456 [TBL] [Abstract][Full Text] [Related]
5. Cytogenical analysis of brain tumors by FISH (fluorescence in situ hybridization) and FCM (flow cytometry). Kasai H; Kawamoto K Noshuyo Byori; 1995 Mar; 12(1):75-82. PubMed ID: 7795734 [TBL] [Abstract][Full Text] [Related]
12. Cytogenetics of pediatric central nervous system tumors. Sainati L; Bolcato S; Montaldi A; Celli P; Stella M; Leszl A; Silvestro L; Perilongo G; Cordero di Montezemolo L; Basso G Cancer Genet Cytogenet; 1996 Oct; 91(1):13-27. PubMed ID: 8908162 [TBL] [Abstract][Full Text] [Related]
13. Chromosome number and carmustine sensitivity in human gliomas. Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658 [TBL] [Abstract][Full Text] [Related]
14. Numerical aberrations of chromosomes 1, 2, and 7 in astrocytomas studied by interphase cytogenetics. Wernicke C; Thiel G; Lozanova T; Vogel S; Witkowski R Genes Chromosomes Cancer; 1997 May; 19(1):6-13. PubMed ID: 9135989 [TBL] [Abstract][Full Text] [Related]
15. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Schröck E; Thiel G; Lozanova T; du Manoir S; Meffert MC; Jauch A; Speicher MR; Nürnberg P; Vogel S; Jänisch W Am J Pathol; 1994 Jun; 144(6):1203-18. PubMed ID: 8203461 [TBL] [Abstract][Full Text] [Related]
16. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
17. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior. Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285 [TBL] [Abstract][Full Text] [Related]
18. DNA content and chromosomal composition of malignant human gliomas. Bigner SH; Bjerkvig R; Laerum OD Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489 [TBL] [Abstract][Full Text] [Related]
19. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation. Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073 [TBL] [Abstract][Full Text] [Related]
20. The cytogenetic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse. Espinosa AB; Tabernero MD; Maíllo A; Sayagués JM; Ciudad J; Merino M; Alguero MC; Lubombo AM; Sousa P; Santos-Briz A; Orfao A Clin Cancer Res; 2006 Feb; 12(3 Pt 1):772-80. PubMed ID: 16467088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]